AI Article Synopsis
- - Sweet's Syndrome (SS) is an inflammatory skin condition characterized by the presence of neutrophils and is a type of neutrophilic dermatosis.
- - There are fewer than 50 documented cases of respiratory complications related to SS, but this article discusses a unique case involving lung transplantation (LT).
- - The study highlights the clinical journey of the first patient who underwent LT for pulmonary SS and suggests that the lung disease may recur in the transplanted organ.
Article Abstract
Sweet's Syndrome (SS), also known as acute febrile neutrophilic dermatosis, is one of several cutaneous inflammatory disorders classified as neutrophilic dermatoses. Respiratory complications are described in <50 cases in the literature, without prior report of lung transplantation (LT). This article explains the clinical course of the first patient to receive LT for pulmonary SS and presents evidence suggesting recurrence of the primary lung disease in the allograft.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411443 | PMC |
| http://dx.doi.org/10.1016/j.chest.2021.04.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular Characteristics of Sweet Syndrome: A Systematic Review.
Exp Dermatol
December 2024
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Sweet syndrome (SS), originally described as acute febrile neutrophilic dermatosis, is a rare inflammatory skin condition, considered the prototype of neutrophilic dermatoses. It is characterised by the sudden onset of well-defined tender papules, plaques and nodules often accompanied by fever, neutrophilia and elevated markers of inflammation. Several variants have been described both clinically and histopathologically.
View Article and Find Full Text PDFSweet's syndrome associated with FLT3 inhibition.
JAAD Case Rep
December 2024
Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
Weight and metabolic changes with long-acting cabotegravir and rilpivirine or bictegravir/emtricitabine/tenofovir alafenamide.
J Acquir Immune Defic Syndr
December 2024
ViiV Healthcare, Durham, NC, United States.
Background: Modest weight and lipid changes have been observed in cabotegravir plus rilpivirine long-acting (CAB+RPV LA) Phase 3/3b studies. The SOLAR study included standardized evaluations of weight and metabolic changes in people living with HIV switching to CAB+RPV LA dosed every 2 months (Q2M) vs. continuing bictegravir/emtricitabine/tenofovir (BIC/FTC/TAF).
View Article and Find Full Text PDFDecitabine-induced Sweet syndrome.
BMJ Case Rep
December 2024
Pharmacy Practice, JSS College of Pharmacy, Mysuru, Karnataka, India
Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare inflammatory skin condition associated with the sudden onset of high-grade fever, painful rashes usually on the upper body, leukocytosis and neutrophilia. Approximately 21% of patients with Sweet syndrome have a concurrent malignancy, 80% of which are linked to haematological diseases, especially myelodysplastic syndrome and acute myeloid leukaemia. This is a case report of a woman in her 50s who was recently diagnosed with acute myeloid leukaemia and was started on decitabine 20 mg/m (40 mg).
View Article and Find Full Text PDFSweet Syndrome Mimicking Flagellate Dermatitis.
Indian J Dermatol
October 2024
Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubiran", Mexico City, México.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!